NCT00759083撤回4 期
Bivalirudin PCI Registry in HIT/HITTS Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Platelet counts
研究概览
简要总结
To monitor the frequency of the development of thrombocytopenia in patients with Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome receiving bivalirudin during Percutaneous Coronary Intervention
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinically Documented History of HIT/HITTS
- •Suspicion of HIT/HITTS
排除标准
- •Bleeding Diathesis
- •Ischemic Stroke
- •Chronic Thrombocytopenia
- •Hematologic Malignancy
- •Contraindication to bivalirudin
- •Pregnant or nursing mothers
研究组 & 干预措施
1
Experimental
Patients with HIT/HITTS who require anticoagulation for PCI
干预措施: bivalirudin (Drug)
结局指标
主要结局
Platelet counts
时间窗: 6, 12, 24, 48 Hours
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)ThrombocytopeniaNCT00594685Carelon Research10
招募中
不适用
Performance Evaluation of the Biological Diagnosis of HITHeparin-induced Thrombocytopenia (HIT)NCT06180785University Hospital, Strasbourg, France894
已完成
不适用
Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive ClinicalHeparin-induced ThrombocytopeniaNCT00748839Centre Hospitalier Universitaire de Saint Etienne2,700
已完成
不适用
Heparin-Induced Thrombocytopenia RegistryHeparin-Induced ThrombocytopeniaNCT00456326Brigham and Women's Hospital242
尚未招募
不适用
Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.Heparin-induced ThrombocytopeniaNCT06066762Assistance Publique - Hôpitaux de Paris200